Rocket Lab USA is trading 5.3% down at $75.82 after investors focused on a wider-than-expected second-quarter loss, below-consensus third-quarter gross-margin guidance, and a delayed Neutron launch timeline.
- Record $234.1 million revenue and $2.36 billion backlog were outweighed by profitability concerns.
- The broader market is only modestly lower, making company-specific earnings concerns the primary catalyst.